ArticleBMC geriatrics2025
Predictive value of qSOFA score for mortality in older patients with dengue fever: a retrospective case-control study.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundDengue fever (DF) in older patients is associated with higher mortality, but optimal mortality prediction approaches remain unclear. We assessed the utility of the quick Sequential Organ Failure Assessment (qSOFA) as a predictive tool in older DF patients.
methodsWe retrospectively included DF patients aged ≥ 65 years who visited our study hospital between September 1, 2015, and December 31, 2015. Demographics, vital signs, comorbidities, laboratory data, and mortality were collected. Accuracy of qSOFA score ≥ 2 in predicting 30-day mortality was evaluated.
results626 older DF patients were recruited (mean age: 74.1 years, nearly equal sex distribution). Mean ± standard deviation of qSOFA score was higher in mortality group vs. survival group (0.6 ± 0.8 vs. 0.1 ± 0, p < 0.01). Logistic regression showed qSOFA score ≥ 2 associated with higher mortality risk (odds ratio: 18.74; 95% confidence interval: 4.37 - 50.64). Adjusted area under receiver operating characteristic was 0.75, and Hosmer-Lemeshow goodness of fit test was 0.58. Sensitivity, specificity, positive predictive value, and negative predictive value of qSOFA score ≥ 2 for predicting mortality were 18.5%, 98.7%, 38.5%, and 96.4%, respectively.
conclusionqSOFA score ≥ 2 is a simple and specific tool for predicting 30-day mortality in older patients with DF, with high specificity and negative predictive value. It can be used to rule out patients at high risk of mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.